bovin
respiratori
syncyti
viru
brsv
recognis
import
pathogen
calf
pneumonia
year
surprisingli
effect
infect
model
studi
immun
respons
pathogenesi
natur
host
establish
present
reproduc
experiment
infect
model
brsv
convent
rear
jersey
calv
thirtyfour
colostrumf
calv
inocul
aerosol
intratrach
inject
brsv
respiratori
diseas
record
brsvinocul
calv
accompani
rise
rectal
temperatur
exhibit
consolid
lung
tissu
diseas
close
resembl
natur
outbreak
brsvrelat
pneumonia
detect
brsv
nasal
secret
lung
tissu
confirm
primari
role
brsv
nine
mockinocul
control
calv
fail
develop
respiratori
diseas
model
valuabl
tool
studi
pathogenesi
brsv
vaccin
efficaci
studi
bovin
respiratori
syncyti
viru
brsv
first
report
switzerland
paccaud
jacquier
subsequ
identifi
worldwid
import
pathogen
acut
respiratori
diseas
calv
baker
velic
bryson
et
al
larsen
uttenth
et
al
earli
attempt
experiment
reproduc
pneumonia
brsv
limit
success
role
brsv
calf
pneumonia
could
therefor
verifi
belknap
et
al
thu
smith
et
al
castleman
et
al
obtain
mild
clinic
diseas
littl
postmortem
evid
pneumonia
follow
singl
inocul
convent
rear
calv
other
obtain
postmortem
evid
brsvpneumonia
littl
clinic
diseas
gnotobiot
calv
gaddum
et
al
thoma
et
al
inocul
intratrach
intranas
four
consecut
day
author
ciszewski
et
al
bryson
et
al
reproduc
moder
sever
sign
respiratori
diseas
well
consolid
lung
tissu
other
achiev
mild
sign
brsvinfect
kimman
et
al
otto
et
al
thu
even
use
rather
heavi
inocul
regimen
reproduc
diseas
inconsist
howev
diseas
recent
reproduc
calv
singl
aerosol
inocul
northamerican
field
isol
brsv
west
et
al
woolum
et
al
research
veterinari
scienc
wwwelseviercomlocatervsc
studi
describ
reliabl
experiment
infect
model
brsv
convent
rear
jersey
calv
use
european
field
isol
brsv
result
present
present
paper
accumul
sever
year
support
paper
publish
west
et
al
woolum
et
al
five
colostrumdepriv
h
old
colostrumf
day
old
jersey
bull
calv
obtain
two
close
dairi
herd
transfer
isol
unit
lindholm
colostrumdepriv
calv
fed
ml
serum
brsvantibodyfre
cattl
electrolyt
solut
day
treat
amoxicillin
synulox
pfizer
day
birth
day
calv
fed
milk
replac
sundkalv
type
dlg
denmark
rear
accord
normal
manag
procedur
dairi
calv
calv
test
weekli
brsvspecif
igm
antibodi
uttenth
et
al
rule
natur
brsvinfect
rear
week
old
inocul
median
valu
week
interquartil
rang
week
free
persist
infect
bovin
viru
diarrhoea
viru
bvdv
eight
experi
conduct
month
tabl
one
colostrumdepriv
exp
iii
seven
colostrumf
exp
iv
va
vb
vi
viii
ix
xi
calv
calv
inocul
day
pi
individu
experi
total
calv
inocul
brsv
kill
day
postinocul
pi
nine
mockinocul
control
calv
kill
day
pi
tabl
four
calv
exp
xi
treat
mg
enrofloxacin
per
kg
baytril
bayer
day
infect
euthanasia
day
pi
colostrumdepriv
calf
calf
kill
day
inocul
lung
lavag
fluid
natur
brsvinfect
calf
sever
pneumonia
viuff
et
al
calf
left
lung
calf
lavag
ml
minim
essenti
medium
glasgow
modif
without
antibiot
mem
lung
lavag
fluid
inoculum
brsv
brsvllf
snapfrozen
liquid
nitrogen
aliquot
ml
kept
filter
lm
extract
lung
tissu
calf
cultur
low
passag
semiprimari
foetal
bovin
lung
cell
fbl
grown
mem
foetal
bovin
serum
harvest
steril
glass
bead
passag
first
third
fourth
cell
cultur
passag
brsv
brsv
frozen
aliquot
ml
use
inoculum
tabl
control
inocula
consist
lung
lavag
fluid
healthi
young
calv
ctr
ctr
llfa
b
uninfect
fbl
cell
ctr
ctr
coinfect
inocula
bacteria
mycoplasma
exclud
convent
isol
method
inocula
cultur
monolay
calf
kidney
cell
ck
examin
cytopathogen
effect
cpe
screen
infect
bovin
entero
viru
bev
bovin
herp
viru
parainfluenza
viru
bovin
adeno
viru
bav
mammalian
reo
virus
reo
bvdv
indirect
immunofluoresc
test
ift
use
pool
virusspecif
hyperimmun
rabbitand
swinesera
antispeci
conjug
dako
glostrup
denmark
presenc
bovin
corona
viru
bcv
investig
elisa
calv
inocul
combin
min
aerosol
exposur
mostli
contain
droplet
less
lm
waechtomat
inhal
vm
kruus
denmark
follow
one
intratrach
inject
aerosol
inoculum
dilut
total
ml
phosphatebuff
salin
pb
administ
mask
cover
nostril
mouth
intratrach
inoculum
dilut
ml
pb
inject
trachea
provok
heavi
inhal
dose
tcid
brsv
administ
way
brsvinfect
calv
nine
control
calv
receiv
brsvneg
inoculum
possibl
loss
infect
aerosol
creation
measur
group
control
calv
brsvinfect
calv
kept
separ
isol
room
inocul
henc
clinic
assess
could
doubl
blind
respiratori
rate
rectal
temperatur
clinic
sign
record
serum
sampl
nasal
swab
collect
daili
day
inocul
day
pi
slaughter
sampl
reduc
nasal
swab
serum
sampl
three
time
weekli
day
pi
nasal
swab
collect
ml
mem
includ
million
iu
penicillin
g
streptomycin
per
liter
mem
calv
anaesthetis
pentobarbit
ml
per
kg
bodyweight
bled
aa
vv
axillari
iliaca
externa
lung
immedi
remov
photograph
taken
extent
macroscop
lesion
rate
score
accord
fig
gross
appear
patholog
chang
lung
tissu
amount
natur
exud
evalu
postmortem
procedur
two
lung
left
lung
lavag
describ
lung
tissu
sampl
g
recov
nine
predetermin
site
repres
dorsal
medial
ventral
part
three
lobe
detect
brsv
antigen
elisa
lung
lavag
fluid
lung
tissu
right
lung
prefer
consolid
area
examin
brsv
isol
fbl
cell
cultur
growth
brsv
demonstr
ift
use
guinea
pig
antibrsv
serum
antiguinea
pig
conjug
dako
glostrup
denmark
tissu
sampl
eight
predetermin
site
right
lung
trachea
nasal
epithelium
ln
tracheobronchali
tonsil
spleen
fix
neutralbuff
formalin
tissu
sampl
examin
convent
histolog
techniqu
presenc
brsvantigen
investig
immunohistochemistri
previous
describ
nasal
swab
pretreat
triton
serva
min
lung
tissu
sampl
tritur
stomach
equal
amount
elisa
buffer
na
hpo
kh
po
nacl
tween
ph
centrifug
g
min
one
standardis
posit
control
includ
everi
nine
sampl
micropl
well
maxisorp
immunopl
nunc
denmark
coat
rabbit
antibrsv
hyperimmun
serum
carbon
buffer
ph
h
step
well
rins
three
time
elisa
buffer
left
five
minut
fourth
rins
step
duplic
twofold
dilut
seri
sampl
follow
first
normal
antibrsv
guinea
pig
serum
altern
column
peroxidaseconjug
rabbit
antiguinea
pig
immunoglobulin
dako
glostrup
denmark
final
opd
substrat
titrat
fig
basi
score
extent
lung
damag
score
given
lung
without
patholog
lesion
score
b
score
c
score
score
e
score
dorsal
aspect
f
score
ventral
aspect
sampl
left
overnight
guinea
pig
sera
normal
rabbit
serum
conjug
incub
min
substrat
reaction
stop
min
room
temperatur
ad
h
plate
read
od
nm
titr
sampl
express
highest
posit
dilut
dilut
consid
posit
od
valu
well
ad
antibrsv
guinea
pig
serum
ratio
od
valu
well
correspond
neg
well
ad
normal
guinea
pig
serum
pn
ratio
sera
day
inocul
day
slaughter
test
antibodi
bav
bcv
elisa
well
neutralis
antibodi
danish
brsv
field
strain
neutralis
brsv
titr
base
neutralis
peroxidas
label
assay
npla
calcul
endpoint
titr
npla
supernat
tritur
lung
tissu
inocul
ck
monolay
examin
cpe
two
cell
cultur
passag
follow
ift
specif
virus
describ
inocula
addit
tissu
right
lung
test
presenc
bav
bcv
antigen
elisa
moreov
lung
spleen
liversampl
investig
aerob
anaerob
bacteria
bronchial
swab
mycoplasma
convent
isol
method
statist
analysi
perform
use
graphpad
instat
tm
graphpad
softwar
san
diego
ca
usa
differ
brsvinocul
mockinocul
calv
tabl
test
statist
signific
use
exact
test
correl
coeffici
use
investig
correl
neutralis
antibodi
clinic
paramet
well
inbetween
clinic
paramet
tabl
baselin
record
clinic
sign
patholog
chang
determin
monitor
calv
inocul
find
nine
control
calv
mockinocul
respect
baselin
set
respiratori
rate
per
minut
rectal
temperatur
consolid
lung
tissu
number
day
clinic
sign
nasal
excret
brsv
day
pi
summaris
tabl
except
febril
reaction
lung
score
one
control
calf
exp
iii
one
control
calf
respiratori
rate
day
pi
exp
iv
sign
diseas
mockinocul
control
anim
tabl
daili
nasal
swab
free
brsv
antigen
lung
tissu
sampl
free
brsv
antigen
live
brsv
respiratori
diseas
induc
eight
experi
tabl
major
brsvinfect
anim
experi
develop
respiratori
rate
min
day
day
pi
sick
anim
accompani
febril
reaction
brsv
excret
demonstr
antigen
nasal
swab
found
brsvinfect
calv
experi
tabl
clinic
sign
viru
shed
accompani
enhanc
vesicular
bronchial
respir
nasal
discharg
cough
vari
degre
anorexia
depress
data
shown
tempor
develop
averag
respiratori
rate
averag
rectal
temperatur
inocul
slaughter
shown
calv
inocul
lung
lavag
fluid
base
inocula
fig
calv
inocul
cell
cultur
passag
inocula
fig
clariti
data
pool
experi
use
brsv
brsv
va
vi
viii
ix
lung
lavag
brsvinoculum
cell
cultur
passag
brsvinocula
induc
increas
averag
respiratori
rate
averag
rectal
temperatur
day
pi
accordingli
two
brsvinocul
calv
kill
day
pi
show
sign
respiratori
diseas
averag
rectal
temperatur
return
normal
level
around
day
pi
averag
respiratori
rate
remain
high
day
pi
base
five
calv
day
pi
averag
rectal
temperatur
brsv
brsv
llfinocul
calv
fig
b
higher
remain
colostrumdepriv
calf
colostrumf
calv
seven
calv
howev
two
colostrumf
calv
sever
febril
reaction
colostrumdepriv
calf
situat
illustr
effect
variat
time
onset
day
sever
clinic
diseas
individu
calv
averag
valu
consequ
also
consid
individu
peak
respiratori
rate
peak
rectal
clinic
sign
excret
brsv
day
day
pi
result
necropsi
accord
fig
temperatur
peak
titr
brsv
nasal
swab
brsvinfect
calv
kill
day
pi
later
tabl
median
valu
min
peak
respiratori
rate
peak
rectal
temperatur
peak
titr
brsv
nasal
swab
peak
rectal
temperatur
correl
peak
respiratori
rate
peak
titr
nasal
swab
lung
score
peak
respiratori
rate
correl
peak
titr
nasal
swab
lung
score
peak
titr
nasal
swab
correl
significantli
lung
score
tabl
substanti
pneumon
lesion
manifest
lobular
dark
red
consolid
area
mucopurul
exud
bronchi
typic
detect
cranioventr
part
lung
day
pi
brsvinocul
calv
tabl
thu
moder
sever
lung
consolid
lung
score
present
calv
kill
day
pi
kill
day
pi
kill
day
pi
kill
day
pi
kill
day
pi
interstiti
oedema
seen
brsvinfect
calv
wherea
emphysema
seen
anim
kill
day
pi
emphysema
especi
pronounc
caudal
lobe
less
frequent
seen
medial
accessori
lobe
incid
emphysema
rose
increas
lung
score
lung
score
lung
score
lung
score
lung
score
data
shown
detail
descript
replic
clearanc
brsv
calv
given
elsewher
viuff
et
al
accept
immunohistochemistri
reveal
brsv
antigen
scatter
bronchial
epitheli
cell
calv
kill
day
pi
high
number
bronchial
epitheli
cell
day
pi
larg
amount
brsv
antigen
found
bronchiolar
alveolar
epitheli
cell
day
pi
fig
patholog
lesion
clearli
associ
presenc
brsv
shift
main
lesion
bronchiti
bronchiol
alveol
observ
correspond
site
brsv
detect
brsv
antigen
detect
lung
tissu
sampl
calv
kill
day
pi
mockinocul
control
calv
microscop
lesion
characterist
brsvrelat
pneumonia
featur
format
syncyti
cell
hyperplasia
bronchial
epithelium
loss
cilia
influx
neutrophil
plug
bronchi
bronchiol
alveoli
collaps
alveoli
interstiti
oedema
emphysema
fig
day
pi
overal
impress
repair
antigen
elisa
detect
brsv
lung
tissu
anim
kill
day
pi
calv
kill
day
pi
lung
tissu
sampl
calv
kill
day
pi
neg
tabl
antigen
titr
brsvposit
lung
sampl
tabl
rang
median
valu
interquartil
rang
detect
brsv
isol
fbl
cell
preced
detect
antigen
elisa
elisa
demonstr
brsv
later
cours
infect
result
colostrumf
calv
kill
day
pi
later
summaris
tabl
total
brsvinocul
calv
develop
respiratori
rate
min
febril
reaction
excret
brsv
anim
kill
day
pi
exclud
lung
score
due
unknown
degre
repair
anim
kill
day
pi
brsv
lung
tissu
due
disappear
antigen
day
pi
thu
lung
score
contain
brsv
antigen
lung
tissu
slaughter
contrast
none
mockinocul
calv
exhibit
sign
diseas
inocul
use
exact
test
five
paramet
significantli
preval
brsvinocul
calv
compar
mockinocul
calv
twotail
pvalu
colostrumdepriv
calv
free
neutralis
brsvspecif
antibodi
time
inocul
colostrumf
calv
vari
level
matern
deriv
neutralis
antibodi
rang
npla
median
valu
npla
interquartil
rang
npla
howev
neutralis
antibodi
titr
inocul
correl
peak
respiratori
rate
r
confidenceinterv
twotail
pvalu
peak
rectal
temperatur
r
confidenceinterv
twotail
pvalu
lung
score
r
confidenceinterv
twotail
pvalu
brsvinocul
colostrumf
calv
low
neutralis
titr
tend
rise
day
pi
calv
higher
preinfect
titr
gener
show
decreas
titr
neutralis
antibodi
respons
appear
develop
slightli
earlier
respons
describ
uttenth
et
al
tabl
correl
inbetween
lung
score
peak
valu
respiratori
rate
rectal
temperatur
titr
nasal
swab
brsvinfect
calv
kill
day
pi
later
sign
cell
cultur
base
inocula
exp
vxi
free
interf
bovin
pathogen
contrast
lung
lavag
fluid
inocula
brsv
brsv
llf
ctr
ctr
llfa
ctr
ctr
llfb
infect
mycoplasma
dispar
exp
iii
iv
ctr
ctrllfa
infect
bcv
exp
iii
postmortem
bronchial
swab
control
calv
brsvinocul
calv
contain
dispar
correspond
figur
ureaplasma
spp
mycoplasma
bovirhini
recov
one
control
two
brsvinocul
calv
three
brsvinfect
calv
pasteurella
multocida
one
pasteurella
avium
two
haemophilu
somnu
lung
tissu
experi
iii
five
calv
excret
bcv
also
detect
lung
tissu
calv
kill
day
pi
seroconvers
bcv
bav
detect
calv
studi
moder
sever
brsvinduc
pneumonia
reproduc
seven
experi
colostrumf
calv
one
experi
colostrumdepriv
calv
nasal
shed
brsv
recoveri
brsv
lung
necropsi
particular
constant
demonstr
brsv
antigen
affect
lung
tissu
brsvinfect
calv
immunohistochemistri
confirm
viru
caus
diseas
describ
experiment
brsvinfect
confin
respiratori
system
demonstr
previous
publish
systemat
screen
tissu
brsv
rtpcr
howev
brsvspecif
rna
detect
tracheobronch
lymph
node
calv
kill
day
pi
larsen
et
al
sever
elicit
paramet
respiratori
diseas
vari
amongst
individu
calv
peak
valu
respiratori
rate
rectal
temperatur
titr
brsv
nasal
swab
significantli
correl
peak
respiratori
rate
rectal
temperatur
correl
significantli
lung
score
likewis
emphysema
sign
sever
respiratori
distress
note
sever
affect
calv
thu
verifi
measur
paramet
respiratori
diseas
associ
caus
brsvinfect
variat
amongst
individu
anim
compar
individu
experi
diseas
pattern
clinic
sign
distribut
charact
lung
lesion
brsvinocul
calv
equal
descript
brsvrelat
pneumonia
natur
infect
calv
belknap
bryson
kimman
et
al
piri
et
al
viuff
et
al
sever
elicit
pneumonia
correl
level
matern
deriv
neutralis
antibodi
inocul
success
inocul
colostrumf
calv
experi
iv
decid
focu
type
calv
establish
natur
experiment
model
brsvinocul
calv
kill
day
pi
sign
diseas
sinc
lung
tissu
sampl
six
calv
posit
brsv
isol
antigen
elisa
probabl
incub
diseas
consist
two
healthi
brsvinocul
calv
kill
day
pi
brsvinfect
bronchial
epitheli
cell
acut
phase
infect
manifest
nasal
viru
excret
febril
reaction
presenc
viral
antigen
lung
almost
end
day
pi
nasal
discharg
cough
consolid
lung
tissu
persist
day
pi
anim
indic
prolong
reparatori
state
lung
tissu
accord
averag
respiratori
rate
present
fig
enhanc
respiratori
rate
seem
ceas
around
day
pi
howev
one
three
calv
kill
day
pi
maintain
enhanc
respiratori
rate
day
recent
experiment
brsvinfect
use
model
confirm
longterm
respiratori
distress
infect
anim
unpublish
data
degre
respiratori
diseas
achiev
experi
distinct
previou
studi
use
singl
inocul
convent
rear
calv
belknap
et
al
howev
elazhari
et
al
west
et
al
woolum
et
al
obtain
compar
level
clinic
sign
one
inocul
one
common
factor
three
success
studi
present
model
exposur
brsv
aerosol
deliv
nebul
extend
period
time
believ
crucial
induct
diseas
exact
mode
transmiss
natur
brsvinfect
yet
unambigu
defin
demonstr
human
rsv
viru
probabl
commonli
transfer
contact
spread
larg
droplet
highrisk
patient
hospit
hall
dougla
mar
et
al
recent
demonstr
experiment
brsv
transmit
air
group
calv
adjac
room
patholog
lesion
seen
combin
aerosol
intratrach
exposur
present
studi
close
resembl
patholog
lesion
acut
brsvrelat
pneumonia
field
bryson
kimman
et
al
piri
et
al
viuff
et
al
moreov
infect
progress
upper
lower
respiratori
tract
day
viuff
et
al
accept
taken
togeth
find
indic
inocul
aerosol
min
probabl
quit
close
field
exposur
calv
due
close
hous
continu
expos
brsv
outbreak
experi
iii
mockinocul
brsvinocul
calv
experienc
coinfect
bcv
presum
origin
bcvinfect
mockinoculum
reach
brsvinocul
calv
contamin
inhal
infect
probabl
caus
slightli
higher
rectal
temperatur
colostrumdepriv
control
calf
day
pi
may
also
influenc
rectal
temperatur
colostrumdepriv
brsvinocul
calf
fig
b
howev
due
limit
number
anim
experi
mere
specul
pasteurella
multocida
p
avium
h
somnu
infrequ
recov
brsvinocul
calv
mycoplasma
isol
brsvinocul
calv
well
control
calv
present
studi
indic
calv
harbour
mycoplasma
time
infect
howev
clear
correl
degre
respiratori
diseas
recoveri
bacteria
bacteria
could
found
anim
widespread
limit
extent
lung
consolid
calv
without
bacteri
infect
display
seriou
lung
lesion
moreov
respiratori
diseas
also
induc
enrofloxacintr
calv
exp
xi
interf
bacteri
mycoplasm
airway
pathogen
studi
also
commonli
recov
respiratori
system
healthi
calv
thoma
smith
woldehiwet
et
al
lung
score
e
brsv
lung
tissu
e
b
b
three
brsvinocul
calv
kill
day
pi
exclud
due
unknown
degre
repair
lung
tissu
b
five
brsvinocul
calv
one
mockinocul
calf
kill
day
pi
exclud
due
disappear
brsv
lung
tissu
day
pi
c
twotail
pvalu
twotail
pvalu
e
twotail
pvalu
et
al
essenti
woldehiwet
et
al
unabl
associ
isol
rate
mycoplasma
respiratori
diseas
calv
besid
charact
induc
pneumonia
present
studi
differ
record
experiment
infect
studi
h
somnu
jackson
et
al
p
multocida
gourlay
et
al
mycoplasma
frii
frii
howard
et
al
tanskanen
henc
though
rule
bacteria
mycoplasma
may
play
contribut
role
clinic
cours
diseas
combin
cell
cultur
base
inoculum
thorough
examin
inocula
well
experiment
calv
bovin
pathogen
made
possibl
exclud
play
primari
etiolog
role
present
studi
thu
consist
experiment
reproduct
moder
sever
diseas
clearli
demonstr
capabl
brsv
primari
etiolog
agent
acut
pneumonia
calv
day
pi
brsv
could
detect
lung
tissu
immunohistochemistri
pcr
larsen
et
al
isol
indic
method
sensit
present
antigen
elisa
howev
elisa
detect
brsv
later
cours
infect
isol
method
lung
tissu
well
nasal
swab
whether
caus
presenc
neutralis
antibodi
inhibit
immunolog
factor
die
brsv
particl
leav
antigen
day
known
conclus
establish
reproduc
experiment
model
brsvinfect
use
danish
field
strain
brsv
model
capabl
induc
clinic
sign
resembl
natur
case
brsvrelat
pneumonia
infect
convent
rear
calv
henc
mimic
field
condit
close
consequ
may
valuabl
tool
studi
pathogenesi
brsvinfect
vaccin
efficaci
studi
studi
issu
publish
elsewher
heegaard
et
al
larsen
et
al
larsen
et
al
et
al
uttenth
et
al
viuff
et
al
accept
